{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:41:26Z","timestamp":1756384886080},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.6998","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T22:11:27Z","timestamp":1494799887000},"page":"1193-1198","source":"Crossref","is-referenced-by-count":4,"title":["Two Cases of Neurolymphomatosis with Fatal Bilateral Vocal Cord Paralysis that were Diagnosed with &lt;sup&gt;18&lt;\/sup&gt;F-fluorodeoxyglucose Positron Emission Tomography (FDG PET)\/CT"],"prefix":"10.2169","volume":"56","author":[{"given":"Yuichiro","family":"Ono","sequence":"first","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kazuma","sequence":"additional","affiliation":[{"name":"Department of Hemato-oncology, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotaro","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Hemato-oncology, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Gan HK, Azad A, Cher L, Mitchell PLR. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro-oncology 12: 212-215, 2010.","DOI":"10.1093\/neuonc\/nop021"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Salm LP, Van der Hiel B, Stokkel MPM. Increasing importance of <sup>18<\/sup>F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun 33: 907-916, 2012.","DOI":"10.1097\/MNM.0b013e3283561881"},{"key":"3","unstructured":"3. Toledano M, Siddiqui MA, Thompson CA, Garza I, Pittock SJ. Teaching NeuroImages: diagnostic utility of FDG-PET in neurolymphomatosis. Neurology 81: e3, 2013."},{"key":"4","unstructured":"4. Leoncini L, Rapha\u00ebl el M, Stein H, Harris NL, Jaffe ES, Kluin PM. Burkitt lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 2008: 262-264."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 104: 3009-3020, 2004.","DOI":"10.1182\/blood-2004-02-0405"},{"key":"6","unstructured":"6. Ferry JA. Burkitt&apos;s lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11: 375-383, 2006."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sariban E, Edwards B, Janus C, Magrath I. Central nervous system involvement in American Burkitt&apos;s lymphoma. J Clin Oncol 1: 677-681, 1983.","DOI":"10.1200\/JCO.1983.1.11.677"},{"key":"8","unstructured":"8. Zelenetz AD, Gordon LI, Wierda WG. NCCN Clinical Practice Guidelines in Oncology. 2nd ed [Internet]. [cited 2015 Apr 30] National Comprehensive Cancer Network, 2015: 1-463. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Teshima T, Akashi K, Shibuya T, et al. Central nervous system involvement in adult T-cell leukemia\/lymphoma. Cancer 65: 327-332, 1990.","DOI":"10.1002\/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W"},{"key":"10","unstructured":"10. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25: 5458-5464, 2007."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115: 5005-5011, 2010.","DOI":"10.1182\/blood-2009-12-258210"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.6998\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:39:10Z","timestamp":1569343150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.6998\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.6998","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}